Trial intelligence / Profile preview

Intravenous tranexamic acid for blood loss reduction during open abdominal myomectomy

PACTR202606687111777Not yet recruiting

Sponsor
John Inya
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Trial of tranexamic acid in Fibromyoma (LM) (2 arms), sponsored by John Inya. Primary endpoints: Intraoperative blood loss during open abdominal myomectomy, Post-operative blood loss during open abdominal myomectomy and 1 more. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

tranexamic acid
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on PACTR202606687111777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202606687111777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call